3D Printed Drugs Market Growing at a CAGR of 9.1% Lead By FabRx, Cycle Pharmaceuticals, Tvasta

According to The Insight Partners market research study titled "3D Printed Drugs Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Dosage Forms and Technology," the global 3D printed drugs market is expected to reach US$ 57.03 Mn in 2027 from US$ 28.52 Mn in 2019. The market is estimated to grow at a CAGR of 9.1% from 2020 to 2027. The report provides trends prevailing in the 3D printed drug ecosystem, and the driving factors and restraining factors pertaining to the market.

Request for sample PDF copy @ https://www.theinsightpartners.com/sample/TIPRE00010199/?utm_source=OpenPR&utm_medium=10144

Leading companies operating in the 3D printed drugs market are Aprecia Pharmaceuticals, LLC, FabRx Ltd, Cycle Pharmaceuticals, GlaxoSmithKline PLC., Astrazeneca, Tvasta, and Merck KGGA, among others.

The global 3D printed drugs market, based on the dosage forms, is segmented into tablets, capsules, multi drug implant, nanoparticles, solutions, and other dosage forms. The tablet segment held the largest share of the market in 2019, and it is further estimated to register the highest CAGR during the forecast period. The growth of the 3D printed drugs market is ascribed to the growing emphasis on personalized medicines and extensive R&D activities.

For instance, FabRx Ltd. completed the world's first in-human clinical study using their proprietary Printlets technology, which relies on personalized 3D printed dosage forms to treat children with a rare metabolic disease. Additionally, the same company launched the first pharmaceutical 3D printer, M3DIMAKER, for the manufacture of personalized medicines in April 2020. Hence, there is a need for new manufacturing systems to prepare personalized medicines, and this potential application of 3D printing for rare diseases is countless. It could help make the medication safer and more attractive to children, thereby propelling the growth of the 3D printed drugs market.

3D Printed Drugs Market - By Dosage Forms

Tablets
Capsules
Multi Drug Implants
Nanoparticles
Solutions
Others

3D Printed Drugs Market - By Technology

Inkjet Printing
Direct Write
Zip Dose
Thermal Inkjet Printing
Fused Deposition Modeling
Powder Bed Printing
Stereolithography (SLA)
Semi Solid Extrusion (SSE)

3D Printed DrugsMarket- By Geography
North America
US
Canada
Mexico
Europe
France
Germany
Italy
UK
Spain
Rest of Europe
Asia Pacific
China
India
South Korea
Japan
Australia
Rest of Asia Pacific
Middle East and Africa
South Africa
Saudi Arabia
UAE
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Directly Purchase Premium Copy of 3D Printed Drugs Market Growth Report at: https://www.theinsightpartners.com/buy/TIPRE00010199/?utm_source=OpenPR&utm_medium=10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

This release was published on openPR.